3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
26
Lymphoma
22
Leukemia, Myeloid, Acute
21
Leukemia
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Non-Hodgkin
17
Myelodysplastic Syndromes
16
Hodgkin Disease
15
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Hematologic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
7
Lymphoma, Follicular
6
Primary Myelofibrosis
5
Neoplasms, Plasma Cell
5
Myeloproliferative Disorders
5
Recurrence
4
Neuroblastoma
4
Graft vs Host Disease
4
Burkitt Lymphoma
4
Breast Neoplasms
4
Polycythemia Vera
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myelomonocytic, Juvenile
3
Ganglioneuroblastoma
3
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Rhabdomyosarcoma
2
Interventions
3-Iodobenzylguanidine
3
cabozantinib
2
tipifarnib
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
lenvatinib
1
guadecitabine
1
fostamatinib
1
copper dotatate CU-64
1
atezolizumab
1
Temozolomide
1
Surgical Procedures, Operative
1
Sunitinib
1
Phenoxybenzamine
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Iodine-131
1
Everolimus
1
Erlotinib Hydrochloride
1
Doxazosin
1
Capecitabine
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pheochromocytoma
×
Stem Cell Transplantation
×
Clear all
No trials found.